Physician profile
Robert D Clark
NPI 1871541441
$1,851.80
in general payments reported to CMS, 2019-2025
15 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,274 · 2020: $257 · 2023: $35.70 · 2024: $109 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $715.62 | 2019-2020 | |
| Astellas Pharma US INC | $289.93 | 2023-2025 | Veozah |
| Teva Pharmaceuticals USA, INC. | $257.48 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.60 | 2019 | |
| Daiichi Sankyo INC. | $150.37 | 2019 | |
| Collegium Pharmaceutical, INC. | $99.36 | 2019 | |
| Pfizer INC. | $43.84 | 2019 | |
| Boston Scientific Corporation | $31.52 | 2025 | Farapulse |
| Biodelivery Sciences International, INC. | $24.20 | 2019 | |
| Lilly USA, LLC | $16.35 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.86 | 2019 | |
| Mdd US Operations, LLC | $14.39 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.33 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $12.68 | 2019 | |
| Nevro Corp. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.